These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 1776760

  • 1. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
    Heiss WD, Szelies B, Kessler J, Herholz K.
    Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
    [Abstract] [Full Text] [Related]

  • 2. Positron emission tomography findings in dementia disorders: contributions to differential diagnosis and objectivizing of therapeutic effects.
    Heiss WD, Herholz K, Pawlik G, Hebold I, Klinkhammer P, Szelies B.
    Keio J Med; 1989 Jun; 38(2):111-35. PubMed ID: 2674513
    [Abstract] [Full Text] [Related]

  • 3. Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition.
    Kessler J, Herholz K, Grond M, Heiss WD.
    Neuropsychologia; 1991 Jun; 29(3):229-43. PubMed ID: 2057055
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. PET studies in dementia.
    Herholz K.
    Ann Nucl Med; 2003 Apr; 17(2):79-89. PubMed ID: 12790355
    [Abstract] [Full Text] [Related]

  • 10. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P, Dani A, Furey ML, Alexander GE, Freo U, Grady CL, Mentis MJ, Mangot D, Simon EW, Horwitz B, Haxby JV, Schapiro MB.
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of piracetam on cerebral glucose metabolism in Alzheimer's disease as measured by positron emission tomography.
    Heiss WD, Hebold I, Klinkhammer P, Ziffling P, Szelies B, Pawlik G, Herholz K.
    J Cereb Blood Flow Metab; 1988 Aug; 8(4):613-7. PubMed ID: 3260597
    [Abstract] [Full Text] [Related]

  • 13. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease.
    Ishii K, Sasaki M, Kitagaki H, Yamaji S, Sakamoto S, Matsuda K, Mori E.
    J Nucl Med; 1997 Jun; 38(6):925-8. PubMed ID: 9189143
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Regional cerebral glucose transport and utilization in Alzheimer's disease.
    Friedland RP, Jagust WJ, Huesman RH, Koss E, Knittel B, Mathis CA, Ober BA, Mazoyer BM, Budinger TF.
    Neurology; 1989 Nov; 39(11):1427-34. PubMed ID: 2812318
    [Abstract] [Full Text] [Related]

  • 20. The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography.
    Foster NL, VanDerSpek AF, Aldrich MS, Berent S, Hichwa RH, Sackellares JC, Gilman S, Agranoff BW.
    J Cereb Blood Flow Metab; 1987 Aug; 7(4):415-20. PubMed ID: 3497161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.